Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick Institute and Vividion Therapeutics discovered a compound that blocks the ...
A new 3D human brain tissue platform developed by MIT researchers is the first to integrate all major brain cell types, ...
NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint mechanism distinct from PD-1/PD-L1 therapies ...
CAR2119’s single-infusion approach offers cost and compliance advantages, though its competitors maintain strong commercial ...
Autoimmune rheumatic diseases (ARDs), such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic ...
Equity Insider News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. /CNW/ — Equity InsiderNews Commentary – MIT and Harvard scientists recently created engineered ...
New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...
"Everything electrical is new" on the 2027 Bolt versus its predecessor, Short said, from switches and wires to control ...
Upcoming safety data release expected to also highlight favorable tolerability profile observed to date and ease-of-use of the regimen that includes cyclophosphamide/fludarabine conditioning, and ...
The team used human stem cells to create embryo-like structures dubbed “hematoids” that mirror some features of early human ...
Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...
A new study from The University of Texas at Arlington has revealed how cells control their mitochondria—the "energy producers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback